Director, Outcomes Research (Prostate and Kidney Cancers)

MSD•North Wales, PA

22h•$190,800 - $300,300•Hybrid

About The Position

The Principal Scientist/Director, Value & Implementation (V&I) Outcomes Research position is within the V&I organization, which includes Global Medical and Scientific Affairs as well as Outcomes Research. Under the guidance of a senior leader, the role supports value evidence outcomes research plans and real-world evidence activities for in-line and pipeline products in prostate and kidney cancers. Its work addresses value evidence needs of clinicians, payers, policymakers, health technology assessment and reimbursement agencies, and health systems globally. Studies may include prospective and retrospective observational research on disease burden, epidemiology, treatment patterns, healthcare resource utilization and costs; physician and patient satisfaction surveys; clinical and patient-reported outcomes assessments; systematic reviews and meta-analyses; and economic modelling. The role also develops U.S. American Managed Care Pharmacy (AMCP) dossiers and Global Value Dossiers for local subsidiaries’ HTA submissions. The incumbent contributes to product development and marketing strategies throughout the product lifecycle, helping define and develop product value to support market and patient access and reimbursement. The position works cross-functionally with clinical development, medical affairs, biostatistics, market access, commercial teams, and country affiliates, and may interact directly with HTA agencies, reimbursement decision makers, and national immunization technical advisory groups.

Requirements

Doctoral degree (PhD, MD, DrPH, ScD, or PharmD with a fellowship) in a relevant discipline such as health services research, outcomes research, epidemiology, public health, health economics, pharmacoeconomics, or pharmacy administration.
Four or more years of post-doctoral experience, or seven or more years of post-master’s experience, in the life science industry conducting NIR and generating value evidence.
Oncology experience.
Skills in data analysis, data management, emotional intelligence, evidence gathering, health economics, market assessments, market opportunity analysis, observational studies, outcomes research, pharmacoeconomics, product management strategy, qualitative analysis, researching, research reporting, stakeholder negotiations, stakeholder relationship management, strategic planning, study design, value propositions, and values assessment.
Ability to make decisions by gathering, analyzing, and interpreting quantitative and qualitative information; evaluating alternatives; and acting consistently with facts and constraints.
Ability to build trust, encourage two-way communication, strengthen relationships, and work with difficult stakeholders while achieving business results.
Ability to build partnerships and leverage relationships within and across work groups.
Ability to create novel solutions with measurable value, experiment with new approaches, and develop differentiated solutions.
Knowledge of the evolving payer and reimbursement environment, including the ability to educate asset teams about the impact of U.S. value assessments and other key market HTA requirements and possible mitigation strategies.

Nice To Haves

Real World Evidence (RWE)

Responsibilities

Partner with Medical Affairs counterparts to develop, execute, and deliver the Value and Implementation plan.
Help achieve and sustain reimbursement and market access for assigned programs and indications.
Assess drivers and barriers to reimbursement and market access, and provide input into clinical, regulatory, payer/access, marketing, and evidence-generation strategies and programs.
Design studies with internal teams and external partners; author study protocols; and develop measurement questionnaires, case report forms, data analysis plans, final study reports, scientific presentations, and publications.
Manage study-related contracts, budgets, vendors, and partners, ensuring study conduct aligns with company policies, standard operating procedures, worldwide regulations, and standards, including Good Pharmacoepidemiology Practice where applicable.
Develop AMCP dossiers for U.S. payers and Global Value Dossiers.
Develop supplementary clinical data packages with markets and the HTA statistics group for submission to HTA agencies.
Support country affiliates in understanding local evidence-generation needs, adapting health economic evaluations, and customizing outcomes research documents such as protocols and reimbursement dossiers to local requirements.
Communicate outcomes research and health economic modelling data effectively to internal teams and external stakeholders.
Maintain awareness of scientific and methodological developments in the therapeutic area.
Build relationships with scientific experts worldwide.
Present outcomes research data at national and international congresses and publish articles in scientific journals.